Search by Drug Name or NDC
NDC 68462-0224-10 Lithium Carbonate 450 mg/1 Details
Lithium Carbonate 450 mg/1
Lithium Carbonate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Glenmark Pharmaceuticals Inc., USA. The primary component is LITHIUM CARBONATE.
MedlinePlus Drug Summary
Lithium is used to treat and prevent episodes of mania (frenzied, abnormally excited mood) in people with bipolar disorder (manic-depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods). Lithium is in a class of medications called antimanic agents. It works by decreasing abnormal activity in the brain.
Related Packages: 68462-0224-10Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Lithium
Product Information
| NDC | 68462-0224 |
|---|---|
| Product ID | 68462-224_40f67069-ceed-4584-b275-fa49492fa895 |
| Associated GPIs | 59500010100410 |
| GCN Sequence Number | 004005 |
| GCN Sequence Number Description | lithium carbonate TABLET ER 450 MG ORAL |
| HIC3 | H2M |
| HIC3 Description | BIPOLAR DISORDER DRUGS |
| GCN | 15730 |
| HICL Sequence Number | 001669 |
| HICL Sequence Number Description | LITHIUM CARBONATE |
| Brand/Generic | Generic |
| Proprietary Name | Lithium Carbonate |
| Proprietary Name Suffix | ER |
| Non-Proprietary Name | Lithium Carbonate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 450 |
| Active Ingredient Units | mg/1 |
| Substance Name | LITHIUM CARBONATE |
| Labeler Name | Glenmark Pharmaceuticals Inc., USA |
| Pharmaceutical Class | Mood Stabilizer [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA091616 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 68462-0224-10 (68462022410)
| NDC Package Code | 68462-224-10 |
|---|---|
| Billing NDC | 68462022410 |
| Package | 1000 TABLET in 1 BOTTLE (68462-224-10) |
| Marketing Start Date | 2011-02-14 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |